ABBOTT LABORATORIES — Director's Dealing 2015

Feb 24, 2015

SEC FORM 4 Page 1 of 1

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0287
Expires:	December 31, 2014
Estimated average burden hours per response:	0.5
1. Name and Address of Reporting Person
Landgraf John C
ABBOTT LABORATORIES [ ABT ]
(Check all applicable)
Director 10% Owner
X Officer (give title below)
Other (specify below)
Executive Vice President
---	---	---
(Last) (First) (Middle)
100 ABBOTT PARK ROAD
02/20/2015
(Street)
ABBOTT
PARK IL 60064-6400
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date
(Month/Day/Year)	2A. Deemed Execution Date, if any
(Month/Day/Year)	3. Transaction Code (Instr. 5)
Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common shares without par value		02/20/2015
Common shares without par value
Common shares without par value
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date
(Month/Day/Year)	3A. Deemed Execution Date, if any
(Month/Day/Year)	4. Transaction Code (Instr. 8)
(Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)
Option (right to buy) (4)	$47	02/20/2015

Explanation of Responses:

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2015.
3. The reporting person disclaims beneficial ownership of all securities held by his son.
4. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,098 on 2/20/16, 55,097 on 2/20/17, and 55,097 on 2/20/18.

John A. Berry, by power of attorney for John C. Landgraf 02/24/2015

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78f(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911015003321/xslF345X03/edgar.xml 2/24/2015